DarioHealth (DRIO) stock price, revenue, and financials

DarioHealth market cap is $132.2 m, and annual revenue was $7.56 m in FY 2019

$132.2 M

DRIO Mkt cap, 17-Sept-2020

$1.8 M

DarioHealth Revenue Q2, 2020
DarioHealth Gross profit (Q2, 2020)636 K
DarioHealth Gross profit margin (Q2, 2020), %35.6%
DarioHealth Net income (Q2, 2020)-4.8 M
DarioHealth EBIT (Q2, 2020)-4.1 M
DarioHealth Cash, 30-Jun-202013.2 M
DarioHealth EV119.6 M

DarioHealth Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

51.0k823.0k2.8m5.2m7.4m7.6m

Revenue growth, %

1514%241%

Cost of goods sold

2.3m1.7m3.4m3.9m5.6m5.0m

Gross profit

(2.2m)(855.0k)(561.0k)1.3m1.8m2.6m

Gross profit Margin, %

(4359%)(104%)(20%)25%24%34%

Sales and marketing expense

2.4m1.1m1.3m4.7m7.7m10.3m11.1m

R&D expense

4.9m3.9m2.6m2.2m3.3m3.7m3.7m

General and administrative expense

6.3m3.6m2.9m3.4m4.7m5.5m5.5m

Operating expense total

13.6m8.6m6.8m10.3m15.7m19.5m20.3m

EBIT

(13.6m)(11.4m)(17.7m)

EBIT margin, %

(22271%)(234%)

Interest expense

369.4k1.5m

Pre tax profit

13.9m12.9m7.1m(10.9m)(15.7m)(17.8m)(17.7m)

Net Income

(13.9m)(12.9m)(17.7m)

Quarterly

USDQ1, 2013Q2, 2013Q3, 2013Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

67.0k175.0k273.0k568.0k669.0k728.0k1.0m1.2m1.4m1.8m2.1m1.9m2.2m1.7m1.9m1.7m1.8m

Cost of goods sold

605.0k585.0k297.0k410.0k404.0k670.0k826.0k652.0k901.0k850.0k1.1m1.2m1.5m1.4m1.7m1.3m995.0k888.0k1.2m

Gross profit

(605.0k)(585.0k)(230.0k)(235.0k)(131.0k)(102.0k)(157.0k)76.0k106.0k360.0k276.0k552.0k522.0k468.0k558.0k326.0k873.0k779.0k636.0k

Gross profit Margin, %

(343%)(134%)(48%)(18%)(23%)10%11%30%20%31%25%25%25%20%47%47%36%

Sales and marketing expense

497.0k664.1k373.0k252.0k252.0k262.0k417.0k519.0k1.1m1.5m1.8m2.2m1.7m1.8m2.3m2.7m3.9m3.0m1.9m4.1m2.6m

R&D expense

675.4k1.4m1.1m1.3m769.0k883.0k441.0k667.0k397.0k521.0k659.0k469.0k1.2m797.0k742.0k1.0m997.0k1.0m991.0k859.0k1.2m825.0k

General and administrative expense

1.9m1.5m1.4m1.3m901.0k412.0k574.0k1.3m905.0k803.0k605.0k2.0m1.1m781.0k861.0k2.9m709.0k973.0k1.7m948.0k5.6m1.3m

Operating expense total

3.1m3.6m2.5m3.0m1.9m1.5m1.3m2.4m1.8m2.5m2.8m4.3m4.5m3.3m3.4m6.2m4.4m5.9m5.7m3.7m10.9m4.8m

Depreciation and amortization

102.0k

EBIT

(3.1m)(3.6m)(3.6m)(2.5m)(1.8m)(4.2m)(4.1m)(3.0m)(2.9m)(5.7m)(3.9m)(5.4m)(5.4m)(2.8m)(10.1m)(4.1m)

EBIT margin, %

(2652%)(418%)(340%)(217%)(164%)(278%)(209%)(239%)(325%)(150%)(607%)(231%)

Interest expense

2.2m1.7m349.0k570.0k139.0k7.4m26.0k6.0k111.0k132.0k20.0k6.0k

Net Income

(5.2m)(5.3m)3.5m(3.3m)(3.1m)(1.6m)3.2m(4.1m)(3.0m)(2.9m)(5.8m)(4.1m)(5.4m)(5.4m)(2.8m)(9.9m)(4.8m)

DarioHealth Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

2.3m1.5m2.7m1.1m3.7m11.0m20.4m

Accounts Receivable

99.3m282.0k168.0k672.0k

Prepaid Expenses

474.8k286.0k935.0k604.0k591.0k267.0k

Inventories

234.0k601.0k888.0k1.2m1.4m1.4m

Current Assets

2.9m2.1m4.3m2.9m6.0m13.3m22.9m

PP&E

1.1m978.0k749.0k901.0k869.0k733.0k648.0k

Total Assets

4.1m3.1m5.1m3.9m7.0m14.1m24.6m

Accounts Payable

586.3k708.0k978.0k37.9m1.9m2.6m1.7m

Short-term debt

317.0k

Current Liabilities

1.5m1.6m1.7m2.9m3.0m5.2m5.2m

Long-term debt

455.0k

Total Debt

772.0k

Common Stock

2.0k2.0k5.0k7.0k8.0k

Preferred Stock

Additional Paid-in Capital

19.9m30.8m41.8m48.4m74.9m98.2m129.0m

Retained Earnings

(36.1m)(43.4m)(55.0m)(71.0m)(89.3m)(110.1m)

Total Equity

(86.4k)(5.3m)(1.6m)(6.5m)3.9m8.9m18.9m

Financial Leverage

-47.6 x-0.6 x-3.2 x-0.6 x1.8 x1.6 x1.3 x

Quarterly

USDQ1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

294.9k7.0m4.5m3.8m1.8m4.2m1.9m981.0k1.9m8.3m6.4m3.3m2.8m3.9m6.3m7.0m5.0m11.4m7.0m8.0m4.6m15.8m13.2m

Accounts Receivable

22.0k3.0k259.0k482.0k372.0k419.0k200.0k348.0k374.0k252.0k278.0k519.0k774.0k624.0k

Prepaid Expenses

408.6k654.3k586.7k615.0k260.0k328.0k419.0k894.0k601.0k610.0k702.0k632.0k768.0k566.0k557.0k523.0k545.0k553.0k392.0k485.0k483.0k

Inventories

22.0k109.0k231.0k207.0k315.0k1.0m1.0m1.1m849.0k717.0k924.0k912.0k1.2m1.0m1.9m1.8m1.5m1.2m1.3m

Current Assets

739.4k7.8m5.2m4.6m2.4m4.7m2.4m1.6m2.7m10.2m8.1m5.6m5.1m5.9m8.6m8.9m7.3m13.5m9.9m10.8m7.2m18.5m15.8m

PP&E

1.3m1.5m1.4m1.1m991.0k1.2m935.0k854.0k796.0k682.0k1.0m1.1m856.0k831.0k811.0k828.0k791.0k758.0k732.0k711.0k674.0k630.0k597.0k

Total Assets

2.1m9.4m6.7m5.7m3.4m6.0m3.4m2.5m3.6m11.0m9.1m6.7m6.0m6.7m9.5m9.8m8.1m14.3m11.4m12.3m8.6m20.0m17.2m

Accounts Payable

708.8k660.6k554.9k539.0k681.0k1.3m844.0k856.0k879.0k556.0k1.0m1.0m1.5m985.0k2.0m1.1m2.1m2.2m3.0m2.4m1.4m1.2m1.6m

Short-term debt

293.0k287.0k

Current Liabilities

1.2m1.3m1.1m1.2m1.8m2.1m1.7m1.5m1.5m1.5m2.0m2.0m2.7m2.8m3.3m2.4m3.9m3.9m7.0m5.7m4.2m4.2m4.7m

Long-term debt

550.0k509.0k477.0k378.0k319.0k

Total Debt

550.0k509.0k477.0k671.0k606.0k

Common Stock

1.5k2.0k2.0k2.0k2.0k2.0k3.0k3.0k4.0k6.0k6.0k6.0k6.0k6.0k6.0k7.0k7.0k7.0k8.0k8.0k8.0k

Preferred Stock

Additional Paid-in Capital

7.2m18.4m19.2m21.7m22.5m27.6m32.9m34.1m37.7m52.6m52.9m54.1m54.9m68.4m64.9m81.2m84.4m94.7m98.5m106.1m106.7m136.7m138.3m

Retained Earnings

(26.2m)(32.6m)(37.7m)(39.9m)(41.7m)(45.0m)(47.7m)(49.7m)(51.7m)(64.5m)(58.8m)(73.9m)(80.2m)(84.3m)(94.6m)(100.0m)(102.8m)(121.3m)(126.1m)

Total Equity

(4.1m)1.8m(839.0k)(1.3m)(3.8m)(4.9m)(4.7m)(5.8m)(4.0m)7.6m5.2m4.4m3.2m4.0m6.1m7.4m4.2m10.4m3.9m6.1m3.9m15.4m12.2m

Financial Leverage

-0.5 x5.1 x-7.9 x-4.5 x-0.9 x-1.2 x-0.7 x-0.4 x-0.9 x1.4 x1.8 x1.5 x1.9 x1.7 x1.5 x1.3 x1.9 x1.4 x3 x2 x2.2 x1.3 x1.4 x

DarioHealth Cash Flow

Quarterly

USDQ1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Net Income

(5.2m)(10.5m)(14.0m)(3.0m)(6.2m)(9.3m)(1.6m)(3.6m)(5.5m)(1.2m)(3.9m)(5.6m)3.2m(9.5m)(3.8m)(2.9m)(8.8m)(12.8m)(5.4m)(10.8m)(13.6m)(9.9m)(13.9m)

Depreciation and Amortization

117.3k313.7k577.7k198.0k358.0k461.0k79.0k163.0k248.0k102.0k191.0k273.0k44.0k101.0k155.0k53.0k101.0k160.0k46.0k93.0k138.0k46.0k92.0k

Accounts Receivable

(22.0k)(3.0k)(257.0k)(256.0k)(146.0k)(193.0k)82.0k(66.0k)(92.0k)(84.0k)(110.0k)(351.0k)(102.0k)48.0k

Inventories

(22.0k)(109.0k)27.0k(81.0k)(404.0k)(410.0k)(517.0k)39.0k171.0k(36.0k)272.0k16.0k164.0k(547.0k)(442.0k)(96.0k)193.0k73.0k

Accounts Payable

128.4k371.1k275.6k(51.0k)39.0k367.0k145.0k163.0k183.0k(422.0k)27.0k49.0k(328.0k)(827.0k)171.0k(740.0k)226.0k351.0k403.0k(190.0k)(1.2m)(417.0k)(77.0k)

Cash From Operating Activities

(971.3k)(3.0m)(5.5m)(2.3m)(4.4m)(6.2m)(1.5m)(2.8m)(4.2m)(2.1m)(3.8m)(6.5m)(3.1m)(5.8m)(8.2m)(2.8m)(4.8m)(8.0m)(4.0m)(9.5m)(12.9m)(4.5m)(7.2m)

Purchases of PP&E

(461.9k)(1.1m)(1.3m)(116.0k)(150.0k)(219.0k)(36.0k)(46.0k)(70.0k)(35.0k)(246.0k)(406.0k)(31.0k)(64.0k)(12.0k)(23.0k)(49.0k)(45.0k)(71.0k)(79.0k)(28.0k)(41.0k)

Cash From Investing Activities

(461.9k)(1.3m)(1.5m)(116.0k)(130.0k)(125.0k)(29.0k)(49.0k)(65.0k)(27.0k)(245.0k)(560.0k)(9.0k)(38.0k)(77.0k)55.0k53.0k20.0k(52.0k)(78.0k)(97.0k)(28.0k)(43.0k)

Cash From Financing Activities

498.0k10.1m10.2m4.0m4.1m8.2m2.0m2.4m4.7m7.7m7.7m7.7m4.8m8.7m13.5m6.0m6.0m15.7m6.6m6.6m

Net Change in Cash

(935.1k)5.8m3.2m1.5m(444.0k)1.9m402.0k(472.0k)455.0k5.6m3.7m668.0k1.7m2.8m5.2m3.3m1.3m7.7m(4.0m)(3.0m)(6.4m)(4.6m)(7.2m)

DarioHealth Ratios

USDQ1, 2013

Financial Leverage

-0.5 x

DarioHealth Operating Metrics

FY, 2016

Patents (US)

2